Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 31, Number 2—February 2025
Research
Epidemiologic and Genomic Surveillance of Vibrio cholerae and Effectiveness of Single-Dose Oral Cholera Vaccine, Democratic Republic of the Congo
Christine Marie George1
, Alves Namunesha1, Kelly Endres, Willy Felicien, Presence Sanvura, Jean-Claude Bisimwa, Jamie Perin, Justin Bengehya, Jean Claude Kulondwa, Ghislain Maheshe, Cirhuza Cikomola, Lucien Bisimwa, Alain Mwishingo, David A. Sack, and Daryl Domman
, Alves Namunesha1, Kelly Endres, Willy Felicien, Presence Sanvura, Jean-Claude Bisimwa, Jamie Perin, Justin Bengehya, Jean Claude Kulondwa, Ghislain Maheshe, Cirhuza Cikomola, Lucien Bisimwa, Alain Mwishingo, David A. Sack, and Daryl Domman
Table
Demographic characteristics of patients with diarrhea in study of effectiveness of single-dose oral cholera vaccine, Democratic Republic of the Congo*
| Characteristics | All patients with diarrhea, n = 750 | Vaccination status |
p value | |
|---|---|---|---|---|
| Received kOCV, n = 93 | No kOCV, n = 657 | |||
| Age, y | ||||
| Median +SD (min–max) | 5 +19 (0–82) | 2 +15 (0–63) | 7 +19 (0–82) | |
| 0–1 | 217/750 (29) | 30/93 (32) | 187/657 (28) | 0.527 |
| 1–4 | 148/750 (20) | 28/93 (30) | 120/657 (18) | 0.011 |
| 5–14 | 96/750 (13) | 11/93 (12) | 85/657 (13) | 0.893 |
| >14 |
289/750 (39) |
24/93 (26) |
265/657 (40) |
0.009 |
| Patient sex | ||||
| F | 368/750 (49) | 45/93 (48) | 323/657 (49) | 0.977 |
| M |
382/750 (51) |
48/93 (52) |
334/657 (51) |
|
| Running water inside home |
93/748 (12) |
12/93 (13) |
81/655 (12) |
1.000 |
| Working mobile phone in home |
565/663 (85) |
78/85 (92) |
487/587 (83) |
0.097 |
| Resided in home, y, median +SD (min–max) |
7 +3 (1–23) |
7 +2 (3–16) |
7 +3 (1–23) |
0.098 |
| Formal education,† y, median +SD (min–max) | 9 +5 (0–23) | 7 +5 (0–15) | 9 +5 (0–23) | 0.028 |
*Values are no. patients in each group/total no. patients analyzed (%) except as indicated. p values compare vaccination status. kOCV, killed whole-cell oral cholera vaccine. †For those patients >18 years of age.
1These first authors contributed equally to this article.
Page created: December 30, 2024
Page updated: January 31, 2025
Page reviewed: January 31, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.